deltatrials
Terminated OBSERVATIONAL NCT02779686

PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration (PIIR)

Sponsor: University of Missouri-Columbia

Conditions Age-Related Macular Degeneration (ARMD)
Updated 6 times since 2017 Last updated: Oct 3, 2016 Started: Jan 31, 2012 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Investigator left institution

Other terminated trials from University of Missouri-Columbia

See all terminations from University of Missouri-Columbia

This observational or N/A phase trial investigates Age-Related Macular Degeneration (ARMD) and is currently terminated or withdrawn. University of Missouri-Columbia leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshotTerminated~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated

  5. Apr 2018 — Jun 2018 [monthly]

    Terminated

    Phase: NA → None

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2018 [monthly]

    Terminated NA

    First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Missouri-Columbia
Data source: University of Missouri-Columbia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations